BioCryst Pharmaceuticals Inc Conference Call Transcript
Good day, and welcome to the BioCryst conference call. (Operator Instructions) Please note today's event is being recorded. I would now like to turn the conference over to John Bluth at BioCryst. Please go ahead.
Thank you. Good morning, and thanks for joining our call this morning. A press release issued earlier today is available on our website and participating with me today on the conference call are CEO, Jon Stonehouse; CFO, Anthony Doyle; Chief Commercial Officer, Charlie Gayer; Chief R&D Officer, Dr. Helen Thackary; Chief Medical Officer, Dr. Ryan Arnold; and Chief Development Officer, Dr. Bill Sheridan. Following our remarks, we'll answer your questions.
Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results, unaudited and forward-looking financial information as well as the company's future performance and/or achievements. These statements are subject to unknown risks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |